Development of an in situ toxicity assay system using recombinant baculoviruses

Biochemical Pharmacology

Volumn 51, Issue 4, 1996, Pages 503-515

  Grant, David F ^a,d   Greene, Jessica F ^a   Pinot, Franck ^a   Borhan, Babak ^a   Moghaddam, Mehran F ^a   Hammock, Bruce D ^a   McCutchen, Bill ^a,e   Ohkawa, Hideo ^b   Luo, Gang ^c   Guenthner, Thomas M ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KOBE UNIVERSITY   (Japan)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e DUPONT COMPANY   (United States)

Author keywords

baculoviruses; cytochrome P450; cytotoxicity; DNA adducts; drug metabolism; epoxides; soluble epoxide hydrolase

Indexed keywords

1,2,7,8 DIEPOXYOCTANE; 9,10 EPOXYOCTADECANOIC ACID; 9,10 EPOXYOCTADECANOIC ACID METHYL ESTER; ALLYLBENZENE EPOXIDE; CARCINOGEN; COMPLEMENTARY DNA; CYTOCHROME P450 ISOENZYME; CYTOTOXIC AGENT; EPOXIDE; EPOXIDE HYDROLASE; ESTRAGOLE EPOXIDE; FATTY ACID DERIVATIVE; MUTAGENIC AGENT; NAPHTHALENE; RADIOISOTOPE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE; STILBENE OXIDE; TOXIC SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; CYTOTOXICITY; DNA ADDUCT; GENE EXPRESSION; INSECT; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TOXICITY TESTING; VIRUS RECOMBINANT; XENOBIOTIC METABOLISM; YEAST;

EID: 19244383028     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(95)02227-9     Document Type: Article

References (60)

1. Williams GM, Methods for evaluating chemical genotoxicity. Annu Rev Pharmacol Toxicol 29: 189-211, 1989.
2. Langenbach R, Smith PB and Crespi C, Recombinant DNA approaches for the development of metabolic systems used in in vitro toxicology. Mutat Res 277: 251-275, 1992.
3. Porter TD and Larson JR, Expression of mammalian P450s in Escherichia coli. Methods Enzymol 206: 108-116, 1991.
4. Guengerich FP, Brian WR, Sari M-A and Ross JT, Expression of mammalian cytochrome P450 enzymes using yeast-based vectors. Methods Enzymol 206: 130-145, 1991.
5. Gonzalez FJ, Aoyama T and Gelboin HV, Expression of mammalian cytochromes P450 using vaccinia virus. Methods Enzymol 206: 85-92, 1991.
6. Clark BJ and Waterman MR, Heterologous expression of mammalian P450 in COS cells. Methods Enzymol 206: 100-108, 1991.
7. Doehmer J, Dogra S, Friedberg T, Monier S, Adesnik M, Glatt H and Oesch F, Stable expression of rat cytochrome P-450IIB1 cDNA in Chinese hamster cells (V79) and metabolic activation of aflatoxin B1. Proc Natl Acad Sci USA 85: 5769-5773, 1988.
8. Yanagawa Y, Sawada M, Deguchi T, Gonzalez FJ and Kamataki T, Stable expression of human CYP1A2 and N-acetyltransferases in Chinese hamster CHL cells: Mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Cancer Res 54: 3422-3427, 1994.
9. Fields WR, Liand Y and Townsend AJ, Protection by transfected glutathoine S-transferase isozymes against carcinogen-induced alkylation of cellular macromolecules in human MCF-7 cells. Carcinogenesis 15: 1155-1160, 1994.
10. Fournel-Gigleux S, Sutherland L, Sabolovic N, Burchell B and Siest G, Stable expression of two human EDP-glucuronosyltransferase cDNAs in V79 cell cultures. Mol Pharmacol 39: 177-183, 1991.
11. Visvikis A, Thioudellet C, Oster T, Fournel-Gigleux S, Wellman M and Siest G, High-level expression of enzymatically active mature human γ-glutamyltransferase in transgenic V79 Chinese hamster cells. Proc Natl Acad Sci USA 88: 7361-7365, 1991.
12. Townsend AJ, Tu C-PD and Cowen KH, Expression of human μ or a class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: Effect on cellular sensitivity to cytotoxic agents. Mol Pharmacol 41: 230-236, 1992.
13. Crespi CL and Thilly WG, Assay for gene mutation in a human lymphoblast line, AHH-1, competent for xenobiotic metabolism. Mutat Res 128: 221-230, 1984.
14. Crespi CL, Langenbach R, Rudo K, Chen YT and Davies RL, Transfection of a human cytochrome P450 gene into the human lymphoblastoid cell line, AHH-1, and use of the recombinant cell line in gene mutation assays. Carcinogenesis 10: 295-301, 1989.
15. Shou M, Korzekwa KR, Krausz KW, Crespi CL, Gonzalez FJ and Gelboin HV, Regio- and stereoselective metabolism of phenanthrene by twelve cDNA-expressed human, rodent, and rabbit cytochromes P-450. Cancer Lett 83: 305-313, 1994.
16. Gonzalez FJ, Crespi CL and Gelboin HV, DNA-expressed human cytochrome P450s: A new age of molecular toxicology and human risk assessment. Mutat Res 247: 113-127, 1991.
17. Gonzalez FJ, Kimura S, Tamura S and Gelboin HV, Expression of mammalian cytochromes P450 using baculovirus. Methods Enzymol 206: 93-99, 1991.
18. Grant DF, Storms DH and Hammock BD, Molecular cloning and expression of murine liver soluble expoxide hydrolase. J Biol Chem 268: 17628-17633, 1993.
19. Kunkel TA, Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci USA 82: 488-492, 1985.
20. O'Reilly DR, Miller LK and Luckow VA, Baculovirus Expression Vectors: A Laboratory Manual, pp. 1-347. Freeman & Co., New York, 1992.
21. Wixtrom RN and Hammock BD, Membrane-bound and soluble fraction epoxide hydrolases. In: Biochemical Pharmacology and Toxicology (Eds. Zakim D and Visa DA) Vol. 1, pp. 1-93. Wiley, New York, 1985.
22. Beetham JK, Tian T and Hammock BD, cDNA cloning and expression of a soluble epoxide hydrolase from human liver. Arch Biochem Biophys 305: 197-201, 1993.
23. Sakaki T, Kominami S, Takemore S, Ohkawa H, Akiyoshi-Shibata M and Yabusaki Y, Kinetic studies on a genetically engineered fused enzyme between rat cytochrome P4501A1 and yeast NADPH-P450 reductase. Biochemistry 33: 4933-4939, 1994.
24. Burke MD and Mayer RT, Ethoxyresorufin: Direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab Dispos 2: 583-588, 1974.
25. Hansen MB, Nielsen SE and Berg K, Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119: 203-210, 1989.
26. Vistica DT, Skehan P, Scudiero D, Monks A, Pittman A and Boyd MR, Tetrazolium-based assays for cellular viability: A critical examination of selected parameters affecting formazan production. Cancer Res 51: 2515-2520, 1991.
27. Corey PF and Ward FE, Buffered potassium peroxymonosulfateacetone epoxidation of α,β-unsaturated acids. J Org Chem 51: 1925-1926, 1986.
28. 18O-labeled epoxides. J Org Chem 59: 4316-4318, 1994.
29. Luo G, Qato MK and Guenthner TM, Hydrolysis of the 2′,3′-allylic epoxides of allylbenzene, estragole, eugenol, and safrole by both microsomal and cytosolic epoxide hydrolases. Drug Metab Dispos 20: 440-445, 1992.
30. Luo G and Guenthner TM, Metabolism of allybenzene oxide and estragole oxide in isolated perfused rat liver. J Pharmocol Exp Ther 272: 588-596, 1995.
31. Chomczynski P, A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15: 532-537, 1993.
32. Pinot F, Grant DF, Beetham JK, Parker AG, Borhan B, Landt S, Jones AD and Hammock BD, Molecular and biochemical evidence for the involvement of the Asp-333-His-523 pair in the catalytic mechanism of soluble epoxide hydrolase. J Biol Chem 270: 7968-7974, 1995.
33. Nourooz-Zadeh J, Uematsu T, Borhan B, Kurth MJ and Hammock BD, Characterization of the cytosolic epoxide hydrolasecatalyzed hydration products from 9,10:12,13-diepoxy stearic esters. Arch Biochem Biophys 294: 675-685, 1992.
34. Dietze EC, Casas J, Kuwano E and Hammock BD, Inhibition of epoxide hydrolase from human, monkey, bovine, rabbit and murine liver by trans-3-phenylglycidols. Comp Biochem Physiol [B] 104: 309-314, 1993.
35. Halarnkar PP, Wixtrom RN, Silva MH and Hammock BD, Catabolism of epoxy fatty esters by the purified epoxide hydrolase from mouse and human liver. Arch Biochem Biophys 272: 226-236, 1989.
36. Nakai K, Ward AM, Gannon M and Rifkind AB, β-Naphthoflavone induction of a cytochrome P-450 arachidonic acid epoxygenase in chick embryo liver distinct from the aryl hydrocarbon hydroxylase and from phenobarbital-induced arachidonate epoxygenase. J Biol Chem 267: 19503-19512, 1992.
37. Park SS, Miller H, Klotz AV, Kloepper-Sams PJ, Stegeman JJ and Gelboin HV, Monoclonal antibodies to liver microsomal cytochrome P-450E of the marine fish Stenotomus chrysops (scup): Cross reactivity with 3-methylcholanthrene induced rat cytochrome P-450. Arch Biochem Biophys 249: 339-350, 1986.
38. Asseffa A, Smith SJ, Nagata K, Gillette J, Gelboin HV and Gonzalez FJ, Novel exogenous heme-dependent expression of mammalian cytochrome P450 using baculovirus. Arch Biochem Biophys 274: 481-490, 1989.
39. Lahde M, Raunio H, Pelkonen O, Karp M and Oker-Blom C, Expression of human placental cytochrome P450 aromatase (CYP19) cDNA in insect cells using a luciferase based baculovirus vector. Biochem Biophys Res Commun 197: 1511-1517, 1993.
40. Huber RE, Gupta MN and Khare SK, The active site and mechanism of the β-galactosidase from Escherichia coli. Int J Biochem 26: 309-318, 1994.
41. Jost LM, Kirkwood JM and Whiteside TL, Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. J Immunol Methods 147: 53-65, 1992.
42. Belyaev AS and Roy P, Development of baculovirus triple and quadruple expression vectors: Co-expression of three or four bluetongue virus proteins and the synthesis of bluetongue virus-like particles in insect cells. Nucleic Acids Res 21: 1219-1223, 1993.
43. Jarvis DL and Garcia A Jr, Long-term stability of baculoviruses stored under various conditions. Biotechniques 16: 508-513, 1994.
44. Kitts PA and Possee RD, A method for producing recombinant baculovirus expression vectors at high frequency. Biotechniques 14: 810-817, 1993.
45. King LA and Possee RD, The Baculovirus Expression System. A Laboratory Guide, pp. 1-229. Chapman & Hall, London, 1992.
46. Gardner DR, Sanders RA, Henry E, Tallmadge DH and Wharton HW, Characterization of used frying oils. Part 1: Isolation and identification of compound classes. J Am Oil Chem Soc 69: 499-508, 1992.
47. Castle L, Mayo A and Gilbert J, Migration of epoxidized soya bean oil into foods from retail packaging materials and from plasticized PVC film used in the home. Food Addit Contam 7: 29-36, 1990.
48. Hamberg M and Hamberg G, Hydroperoxide-dependent epoxidation of unsaturated fatty acids in the broad bean (Vicia faba L.). Arch Biochem Biophys 283: 409-416, 1990.
49. Laethem RM and Koop DR, Identification of rabbit cytochromes P450 2C1 and 2C2 as arachidonic acid epoxygenases. Mol Pharmacol 42: 958-963, 1992.
50. Oliw EH, Oxygenation of polyunsaturated fatty acids by cytochrome P450 monooxygenases. Prog Lipid Res 33: 329-354, 1994.
51. Hayakawa M, Kosaka K, Sugiyama S, Yokoo K, Aoyama H, Izawa Y and Ozawa T, Proposal of leukotoxin, 9,10-epoxy-12-octadecenoate, as a burn toxin. Biochem Int 21: 573-579, 1990.
52. Sugiyama S, Hayakawa M, Nagai S, Ajioka M and Ozawa T, Leukotoxin, 9,10-epoxy-12-octadecenoate, causes cardiac failure in dogs. Life Sci 40: 225-231, 1987.
53. Sugiyama S, Hayakawa M, Hanaki Y, Ogawa T and Ozawa T, Leukotoxin and pulmonary injury. Nippon Ronen lgakkai Zasshi (Jpn J Geriatr) 27: 161-165, 1990.
54. van Bladeren PJ, Vyas KP, Sayer JM, Ryan DE, Thomas PE, Levin W and Jerina DM, Stereoselectivity of cytochrome P-450c in the formation of naphthalene and anthracene 1,2-oxides. J Biol Chem 259: 8966-8973, 1984.
55. Forkert PG, Parkinson A, Thaete LG and Malkinson AM, Resistance of murine lung tumors to xenobiotic-induced cytotoxicity. Cancer Res 52: 6797-6803, 1992.
56. Tingle MD, Pirmohamed M, Templeton E, Wilson AS, Madden S, Kitteringham NR and Park BK, An investigation of the formation of cytotoxic, genotoxic, protein-reactive and stable metabolites from naphthalene by human liver microsomes. Biochem Pharmacol 46: 1529-1538, 1993.
57. Buckpitt AR, Chang AM, Weir A, Van Winkle L, Duan X, Philpot R and Plopper C, Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters. Mol Pharmacol 47: 74-81, 1995.
58. Chichester CH, Buckpitt AR, Chang A and Plopper CG, Metabolism and cycotoxicity of naphthalene and its metabolites in isolated mutine Clara cells. Mol Pharmacol 45: 664-672, 1994.
59. Gordon GB, Spielberg SP, Blake DA and Balasubramanian V, Thalidomide teratogenesis: Evidence for a toxic arene oxide metabolite. Proc Natl Acad Sci USA 78: 2545-2548, 1981.
60. Bolton JL, Acay NM and Vukomanovic V, Evidence that 4-allyl-o-quinones spontaneously rearrange to their more electrophilic quinone methides: Potential bioactivation mechanism for the hepatocarcinogen safrole. Chem Res Toxicol 7: 443-450, 1994.